AMGEN: PHASE 3 OASIZ 303 STUDY OF DAZODALIBEP IN MODERATE-TO-SEVERE SYMPTOMATIC SJÖGREN’S DISEASE EXPECTED TO COMPLETE IN Q4 2026

Reuters · 2d ago

Please log in to view news